| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 07/30/2003 | EP0835252B1 Triazole antifungal agents |
| 07/30/2003 | CN1433420A Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof |
| 07/30/2003 | CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433408A Aminothiazole inhibitors of cyslin dependent kinases |
| 07/30/2003 | CN1116266C Process for preparation of acylated cyclic 1,3-dicarbonyl compounds |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6599911 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/29/2003 | US6599902 For treating or preventing a protein kinase related disorder |
| 07/29/2003 | CA2247398C Herbicidal sulfonamide derivatives |
| 07/24/2003 | WO2003060078A2 Heterocyclic modulators of nuclear receptors |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery |
| 07/24/2003 | US20030139463 Anticancer agents; antiarthritic agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/23/2003 | EP1328518A1 Imidazolium salts and the use of these ionic liquids as a solvent |
| 07/23/2003 | EP1155013B1 Heterocyclic benzenesulphonamide compounds as bradykinine antagonists |
| 07/23/2003 | EP1056742B1 Anti-viral pyrimidine derivatives |
| 07/23/2003 | EP0763529B1 Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
| 07/23/2003 | CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections |
| 07/23/2003 | CN1432014A Triazole compounds having amide linkage |
| 07/23/2003 | CN1432013A Imidazole derivatives or salts thereof and drugs contg. derivatives or salts |
| 07/22/2003 | US6596747 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH) |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596130 Using ionic liquids as solvents resulted in high yields with dramatically reduced reaction times |
| 07/17/2003 | WO2003056922A1 Substituted thiazolyl sulfonyl urea compounds |
| 07/17/2003 | US20030135044 Novel gamma secretase inhibitors |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134845 Biologically active vasopressin agonist metabolites |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/10/2003 | WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003022274A3 2-aroylimidazole compounds for treating cancer |
| 07/10/2003 | WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 07/10/2003 | US20030130509 Process to produce 3-carbon amino alcohol salts |
| 07/10/2003 | US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis. |
| 07/10/2003 | US20030130332 Method for prophylaxis and treatment of diabetic complications with 4[alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives |
| 07/10/2003 | US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/10/2003 | US20030130318 2-sulfonamido-thiazole derivatives |
| 07/10/2003 | US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators |
| 07/10/2003 | US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 07/10/2003 | US20030130260 Aryl fused azapolycyclic compounds |
| 07/10/2003 | US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/10/2003 | CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP0973768B1 Azole compounds, their production and their use |
| 07/09/2003 | EP0966490B1 Catalyst compositions for the polymerization of olefins |
| 07/09/2003 | EP0906292B1 Triazolyl mercaptides and their use as microbicides |
| 07/09/2003 | EP0900208B1 Acyl mercapto-triazolyl derivatives and the use thereof as microbicides |
| 07/09/2003 | CN1429231A Ligand and complex for catalytically bleaching substate |
| 07/09/2003 | CN1429214A Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production |
| 07/08/2003 | CA2260277C Imidazolate sulfuryl difluorides |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053918A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2002062295A3 Pyridine-substituted benzanilides as potassium ion channel openers |
| 07/03/2003 | US20030125370 Treating or preventing protein kinase related disorders in a organism, such as cancer, diabetes, autoimmune disoders, hyperproliferation diosrders, osteoarthritis, rhematoid arthritis, angiogenesis, immunological disorders |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | CA2471038A1 Process for the preparation of perfluoroalkanesulfonic acid esters and salts thereof |
| 07/02/2003 | EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 07/02/2003 | EP1322638A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition |
| 07/02/2003 | EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
| 06/26/2003 | WO2003051870A1 Novel compounds |
| 06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2001066551A8 Azole compounds as therapeutic agents for fungal infections |
| 06/26/2003 | US20030119868 Gyrase inhibitors and uses thereof |
| 06/26/2003 | US20030119856 Thiazole compounds useful as inhibitors of protein kinase |
| 06/26/2003 | US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions |
| 06/26/2003 | US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections |
| 06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/25/2003 | EP1320520A1 Sulfonylguanidine |
| 06/25/2003 | EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 06/25/2003 | EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/25/2003 | CN1426451A Composition and method for bleaching substrate |